Authors' Reply: “Advances in Antiviral Strategies for Oral Herpes Infections in Immunocompromised Patients”

Nishant Burnase; Bikash Kumar; Padmanabha Kumar; Rajathirajan Siva Dharshini; Reena Das; Anand Barapatre

doi:10.1111/odi.70323

journal article Mar 29, 2026

Authors' Reply: “Advances in Antiviral Strategies for Oral Herpes Infections in Immunocompromised Patients”

Nishant Burnase Bikash Kumar Padmanabha Kumar Rajathirajan Siva Dharshini Reena Das

Anand Barapatre

Oral Diseases · Wiley

View at Publisher Save 10.1111/odi.70323

Topics

No keywords indexed for this article. Browse by subject →

References

9

[1]

10.1111/odi.70090

[2]

Dambrosi S. "Neurovirulence and Latency of Drug‐Resistant Clinical Herpes Simplex Viruses in Animal Models" Journal of Medical Virology (2010) 10.1002/jmv.21773

[3]

Epstein J. B. "Herpes Simplex Virus in Immunocompromised Patients: Growing Evidence of Drug Resistance" Oral Surgery, Oral Medicine, and Oral Pathology (1991) 10.1016/0030-4220(91)90188-i

[4]

Hanine Y. "Comment on ‘Advances in Antiviral Strategies for Oral Herpes Infections in Immunocompromised Patients’" Oral Diseases (2026)

[5]

Huntjens D. W. "Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients" Pharmaceutics (2023) 10.3390/pharmaceutics15010163

[6]

Kennedy P. G. E. "A Molecular and Cellular Model to Explain the Differences in Reactivation From Latency by Herpes Simplex and Varicella–Zoster Viruses" Neuropathology and Applied Neurobiology (1994) 10.1111/j.1365-2990.1994.tb00982.x

[7]

Okuda T. "Suppression of Generation and Replication of Acyclovir‐Resistant Herpes Simplex Virus by a Sensitive Virus" Journal of Medical Virology (2004) 10.1002/jmv.10562

[8]

Piperi E. "Management of Oral Herpes Simplex Virus Infections: The Problem of Resistance. A Narrative Review" Oral Diseases (2024) 10.1111/odi.14635

[9]

Suzutani T. "Analysis of the Relationship Between Cellular Thymidine Kinase Activity and Virulence of Thymidine Kinase‐Negative Herpes Simplex Virus Types 1 and 2" Microbiology and Immunology (1995) 10.1111/j.1348-0421.1995.tb03271.x

Metrics

0

Citations

9

References

Details

Published: Mar 29, 2026
License: View

Authors

N

Nishant Burnase

Virus Research and Diagnostic Laboratory (VRDL) Chhattisgarh Institute of Medical Sciences Bilaspur Chhattisgarh India

B

Bikash Kumar

Amity Institute of Biotechnology Amity University Raipur Chhattisgarh India; Department of Oral and Maxillofacial Pathology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences Saveetha University Chennai Tamilnadu India; Department of Bioscience and Biomedical Engineering Indian Institute of Technology Indore Indore Madhya Pradesh India

P

Padmanabha Kumar

Department of Oral and Maxillofacial Pathology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences Saveetha University Chennai Tamilnadu India

R

Rajathirajan Siva Dharshini

Microbiology Team Cavinkare R&D Centre Chennai Tamil Nadu India; Centre for Global Health Research, Saveetha Medical College and Hospital Saveetha Institute of Medical and Technical Sciences Kancheepuram Dt Tamil Nadu India

R

Reena Das

Department of Oral and Maxillofacial Pathology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences Saveetha University Chennai Tamilnadu India

A

Anand Barapatre

Indira Gandhi National Tribal University Madhya Pradesh India

Cite This Article

Nishant Burnase, Bikash Kumar, Padmanabha Kumar, et al. (2026). Authors' Reply: “Advances in Antiviral Strategies for Oral Herpes Infections in Immunocompromised Patients”. Oral Diseases. https://doi.org/10.1111/odi.70323

Authors' Reply: “Advances in Antiviral Strategies for Oral Herpes Infections in Immunocompromised Patients”

You May Also Like